Marathon Asset Management (UK)’s CME Group CME Stock Holding History

Marathon Asset Management (UK)’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21M	Sell	95,173 -24,958	-21%	-$6.9M	0.85%	38
2026 Q1	$35.5M	Buy	120,131 +14,459	+14%	+$4.29M	1.36%	29
2025 Q4	$28.9M	Sell	105,672 -10,532	-9%	-$2.86M	1.11%	36
2025 Q3	$31.4M	Sell	116,204 -43,143	-27%	-$11.7M	1.16%	34
2025 Q2	$43.9M	Sell	159,347 -2,267	-1%	-$616K	1.41%	28
2025 Q1	$42.9M	Sell	161,614 -18,098	-10%	-$4.46M	1.31%	26
2024 Q4	$42.7M	Buy	179,712 +26,913	+18%	+$6.19M	1.19%	32
2024 Q3	$33.7M	Sell	152,799 -16,200	-10%	-$3.35M	0.93%	40
2024 Q2	$33.2M	Sell	168,999 -11,000	-6%	-$2.27M	1.04%	40
2024 Q1	$38.8M	Sell	179,999 -11,998	-6%	-$2.52M	1.03%	42
2023 Q4	$41.3M	Sell	191,997 -6,098	-3%	-$1.3M	1.16%	34
2023 Q3	$39.7M	Buy	198,095 +38,910	+24%	+$7.73M	1.23%	33
2023 Q2	$29.5M	Buy	+159,185	New	+$29.4M	0.83%	46
2021 Q4	–	Sell	-207,737	Closed	-$40.2M	–	96
2021 Q3	$40.2M	Sell	207,737 -6,070	-3%	-$1.23M	0.49%	67
2021 Q2	$45.5M	Buy	213,807 +10,401	+5%	+$2.2M	0.55%	67
2021 Q1	$41.5M	Sell	203,406 -6,221	-3%	-$1.23M	0.58%	68
2020 Q4	$38.7M	Buy	+209,627	New	+$35.7M	0.54%	74

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Marathon Asset Management (UK)'s CME Position: Q2 2026 in Review

Marathon Asset Management (UK) reduced its CME Group (CME) stake by 21% in Q2 2026, selling an estimated $6.9M and leaving 95,173 shares worth $21M. The position accounts for 0.85% of the portfolio, ranked #38.

Marathon Asset Management (UK) first reported a position in CME in Q4 2020 and has held it in 17 quarters since. The position peaked at $45.5M in Q2 2021. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Marathon Asset Management (UK) held 95,173 shares of CME Group worth $21M as of Q2 2026.
Marathon Asset Management (UK) sold 24,958 CME Group shares in Q2 2026, an estimated $6.9M.
CME Group made up 0.85% of Marathon Asset Management (UK)'s portfolio in Q2 2026, its #38 holding.
Marathon Asset Management (UK) first reported a position in CME Group in Q4 2020 and has held it in 17 quarters since.
Marathon Asset Management (UK)'s CME Group position peaked at $45.5M in Q2 2021.
1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Marathon Asset Management (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.